TrialThe American journal of hospice & palliative care2020

Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases.

Kathleen M Akgün et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.